Back to search
Clonal Cytopenia of Uncertain Significance
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Clonal Cytopenia of Uncertain Significance trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Clonal Cytopenia of Uncertain Significance trials you may qualify forThe purpose of this clinical trial is to test how well the drug luspatercept works in improving low blood cell counts in people with clonal cytopenias of uncert…
This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NGS…
This phase II trial tests how well canakinumab works to prevent progression to cancer in patients with clonal cytopenias of unknown significance (CCUS). CCUS is…
Clonal hematopoiesis (CH) is characterized by the overproduction of blood cells derived from a single hematopoietic stem and progenitor cell (HSPC) harboring ce…
The proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions has been released by an international consensus gr…